cell - International Biopharmaceutical Industry

news

Adicet data hints at early promise for ‘gamma delta’ cell therapy

Dive Brief: Adicet Bio on Thursday reported updated results from an early-stage study testing a blood cancer treatment that harnesses gamma delta T cells, an emerg...

30 May 2022 news Adicet | cell

Continue Reading →

news

Bayer backs out of Atara cell therapy deal

Dive Brief: Bayer plans stop developing cancer cell therapies with Atara Biotherapeutics, informing the California biotech company that it will terminate a researc...

22 May 2022 news Atara | Bayer

Continue Reading →

news

Versant-backed startup launches with plans to broaden cell therapy’s reach

Stem cell transplants can effectively cure a wide range of diseases, from blood cancers to rare genetic disorders. They've been used for decades and are considered st...

14 April 2022 news blood | cancers

Continue Reading →

news

Novartis turns cell therapy skill into contract manufacturing deal

Dive Brief: Novartis will manufacture an experimental cancer cell therapy for the small Philadelphia-based Carisma Therapeutics in a deal that marks another early ...

14 March 2022 news cell | contract

Continue Reading →

news

Pfizer’s big bet on mRNA, Biogen ‘proven wrong’ on Aduhelm price and the next cell therapies

Biotechnology stocks ended the first day of the J.P. Morgan Healthcare Conference in the green, but only barely. By Monday afternoon, a closely followed index of the ...

14 January 2022 news Alzheimer | cell

Continue Reading →

news

Allogene cleared by FDA to resume ‘off the shelf’ cancer cell therapy trials

The Food and Drug Administration has cleared Allogene Therapeutics to resume testing its cancer cell therapies after determining the company's technology wasn't to bl...

14 January 2022 news Allogene | cancer

Continue Reading →

news

Takeda reels in a cell therapy research partner with ‘build-to-buy’ deal

Takeda, which has made cell and gene therapy a research focus, is turning to partnerships and acquisitions to help fill out its pipeline. In addition to the GammaDelt...

29 October 2021 news allogeneic | cell

Continue Reading →

news

The International Society for Stem Cell Research brings researchers together in Melbourne

The conference is the world’s largest stem cell meeting and will attract more than 2,500 delegates from 60 countries, delivering around $13 million in economic impact...

22 June 2018 news cell | conference

Continue Reading →

news

Celonic AG Appoints Soenke Brunswieck as Vice President Cell & Gene Therapy

Celonic AG, the Swiss biologics contract development and manufacturing organization, has appointed Soenke Brunswieck as Vice President Cell & Gene Therapy to esta...

8 May 2018 news AG | Brunswieck

Continue Reading →

news

Achieving Large-Scale Cell and Gene Therapy Manufacturing

Initial clinical successes with cell and gene therapies have driven significant investment in these next-generation technologies by both large bio/pharma companies an...

4 May 2018 news achieving | cell

Continue Reading →